Wall Street Holds Its Breath: What’s Brewing Beneath Lucid Diagnostics’ Quiet Period?
Lucid Diagnostics is nearing the end of a critical lock-up period, restricting key insiders from selling or transferring shares until May 25. This lock-up is designed to prevent sudden stock sales that could trigger volatility and impact share prices. The expiration may
